Data suggest that in gastrointestinal diseases, cGAS-STING activation is key for the onset of colitis and CRC [105], while in other cancer types such as prostate, the accumulation of cytosolic DNA increases disease progression from non-malignant to hyperplasia to stage II [106]. This evidence concerns the gene STING1 and cancer.